Fox News
EXCLUSIVE: Trump’s FDA nominee vows new abortion pill safety review after pressure from Sen Hawley
Friday, November 20, 2026
Dr. Heidi Overton, nominated to lead the Food and Drug Administration, committed to a timeline for a delayed mifepristone safety study, according to Sen. Josh Hawley's office. Mifepristone is a medication used in abortion procedures. No additional details about the timeline or study scope were provided.
Original reporting:
